Literature DB >> 7535637

Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium.

N Yahi1, S Baghdiguian, J Fantini.   

Abstract

The human colonic epithelial cell line HT-29 can be productively infected with various HIV-1 and HIV-2 isolates that are highly cytopathic for T lymphocytes. In each case, a chronically infected HT-29 cell line can be established, and progeny viruses retain their original properties including high cytopathogenicity for T cells. Inasmuch as AIDS vaccines should include viral isolates capable of infecting mucosal epithelial cells, it may be useful to produce these isolates in such cells at a large scale. We describe here a microcarrier-based culture system allowing the production of infectious viruses from HT-29 cells grown in a chemically defined serum-free medium (Dulbecco's modified Eagle's medium/F12, HEPES 15 mM, pH 7.4, transferrin 5 micrograms/ml, selenium 10 ng/ml). The yield of HIV-1 from microcarrier cultures (275 ng of p24gag/ml) was greater than the yield from conventional culture flasks (122 ng of p24gag/ml). This virus, produced in serum-free medium, can be used either as a viral stock or as a source for HIV-1 proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7535637     DOI: 10.1007/BF02631339

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  16 in total

1.  Large-scale concentration and purification of virus suspension from microcarrier culture for the preparation of inactivated virus vaccines.

Authors:  A L van Wezel; J A van Herwaarden; E W van de Heuvel-de Rijk
Journal:  Dev Biol Stand       Date:  1979

2.  Human T-lymphoblastoid cells selected for growth in serum-free medium provide new tools for study of HIV replication and cytopathogenicity.

Authors:  N Yahi; J Fantini; S Baghdiguian; J C Chermann
Journal:  J Virol Methods       Date:  1991 Sep-Oct       Impact factor: 2.014

3.  Selected human immunodeficiency virus replicates preferentially through the basolateral surface of differentiated human colon epithelial cells.

Authors:  J Fantini; S Baghdiguian; N Yahi; J C Chermann
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

4.  Production of an inactivated rabies vaccine in primary dog kidney cells.

Authors:  A L van Wezel; G van Steenis
Journal:  Dev Biol Stand       Date:  1978

5.  Large-scale production of human fibroblast interferon.

Authors:  J Van Damme; A Billiau
Journal:  Methods Enzymol       Date:  1981       Impact factor: 1.600

6.  Propagation of poliovirus in microcarrier cultures of three monkey kidney cell lines.

Authors:  B Mered; P Albrecht; H E Hopps; J C Petricciani; J Salk
Journal:  J Biol Stand       Date:  1981

7.  Effect of VIP on the glycogen metabolism of human colon adenocarcinoma cells studied by 13C nuclear magnetic resonance spectroscopy.

Authors:  J P Galons; J Fantini; J Vion-Dury; P J Cozzone; P Canioni
Journal:  Int J Cancer       Date:  1990-01-15       Impact factor: 7.396

8.  Tumor necrosis factor-alpha stimulates both apical and basal production of HIV in polarized human intestinal HT29 cells.

Authors:  J Fantini; C Bolmont; N Yahi
Journal:  Immunol Lett       Date:  1992-09       Impact factor: 3.685

9.  Inhibition of human immunodeficiency virus infection in human colon epithelial cells by recombinant interferon-gamma.

Authors:  N Yahi; S Baghdiguian; C Bolmont; J Fantini
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

10.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

Authors:  R C Gallo; S Z Salahuddin; M Popovic; G M Shearer; M Kaplan; B F Haynes; T J Palker; R Redfield; J Oleske; B Safai
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

View more
  1 in total

1.  Inactivation of human immunodeficiency virus type 1 by porphyrins.

Authors:  Andrei N Vzorov; Dabney W Dixon; Jenna S Trommel; Luigi G Marzilli; Richard W Compans
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.